EGT-30190-15774
5 vaccinations
5 coded responses
64 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 088 / NJ
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-03
Dose 3 — Pfizer-BioNTech
- 2021-09-03
- 2021-09-04
- 2021-09-06
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-10
- 2021-09-17
- 2021-09-24
-
2021-10-01
Survey response — day 28, dose 3MedDRA: Exposure to communicable disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Exposed to rhinovirus from symptomatic nurse coworker with whom I spent last Friday doing endoscopy all day despite her and I both wearing masks, told me around midday she& source case grand daugh tested Covid19 neg consistently & rhinovirus positiveMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-12-04
- 2022-03-04
-
2022-03-29
Dose 4 — Pfizer-BioNTech
- 2022-03-30
- 2022-03-31
- 2022-04-01
- 2022-04-02
- 2022-04-03
- 2022-04-04
- 2022-04-05
- 2022-04-12
- 2022-04-19
- 2022-04-26
-
2022-05-03
Survey response — day 35, dose 4MedDRA: Chills, Cough, Hyperhidrosis, Myalgia, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Self-medication, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Sneezing, rhinorrhea, slight cough, feverish, sweating, chills, muscle aches and pains starting Saturday, April 30, tested positive Sunday, May 1, on home rapid antigen nucleocapsid Coronavirus test, started Paxlovid that evening, now resolved and g. · Healthcare visit (other): CVS Pharmacy - I prescribed for myself as I am a doctor.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — day 35, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-05-04
-
2022-05-04
Call successfulCompleted over the phone
-
2022-05-10
Survey response — day 42, dose 4MedDRA: COVID-19, Office visit, Pre-existing disease, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Therapeutic response unexpected — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Covid19 home rapid antigen test positive May 1, Covid19 symptoms resolved May 2, PCR positive May 4, rapid antigen negative May 6. Paxlovid 300 mg bid evening May 1-6 morning; side effects dysgeusia, diarrhea, rectal pain resolved. Arthritis cured! · Healthcare visit (other): Employee Health ServiceMedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-11
Call successfulDoes not wish to fill out VAERS report
-
2022-06-30
Survey response — 3 months, dose 4MedDRA: COVID-19, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rebound COVID19 after Paxlovid treated by repeated course of Paxlovid successfully. · Healthcare visit (other): Self treatment with colleague physician advice after literature search and consultationMedDRA releases: 2024-11 · check-in free text available
-
2022-06-30
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-07-01
- 2022-07-01
- 2022-07-01
-
2022-07-02
Call successfulDoes not wish to fill out VAERS report
-
2022-09-28
Dose 5 — Pfizer-BioNTech
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
-
2022-12-28
Survey response — 3 months, dose 5MedDRA: Large intestine polyp — Feeling: GoodFree text: Colon polypMedDRA releases: 2024-11 · check-in free text available
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-03 | Pfizer-BioNTech | No |
| 4 | 2022-03-29 | Pfizer-BioNTech | No |
| 5 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 1
Free text
Release 9 — day 28, dose 3
Symptoms: Exposed to rhinovirus from symptomatic nurse coworker with whom I spent last Friday doing endoscopy all day despite her and I both wearing masks, told me around midday she& source case grand daugh tested Covid19 neg consistently & rhinovirus positive cut off by CDC
Release 11 — day 35, dose 4
Symptoms: Sneezing, rhinorrhea, slight cough, feverish, sweating, chills, muscle aches and pains starting Saturday, April 30, tested positive Sunday, May 1, on home rapid antigen nucleocapsid Coronavirus test, started Paxlovid that evening, now resolved and g. cut off by CDC
Healthcare visit (other): CVS Pharmacy - I prescribed for myself as I am a doctor.
Release 11 — day 42, dose 4
Symptoms: Covid19 home rapid antigen test positive May 1, Covid19 symptoms resolved May 2, PCR positive May 4, rapid antigen negative May 6. Paxlovid 300 mg bid evening May 1-6 morning; side effects dysgeusia, diarrhea, rectal pain resolved. Arthritis cured! cut off by CDC
Healthcare visit (other): Employee Health Service
Release 12 — 3 months, dose 4
Symptoms: Rebound COVID19 after Paxlovid treated by repeated course of Paxlovid successfully.
Healthcare visit (other): Self treatment with colleague physician advice after literature search and consultation
Release 12 — 3 months, dose 5
Symptoms: Colon polyp
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Self-medication | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to communicable disease | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Large intestine polyp | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Therapeutic response unexpected | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release